Related Experiment Video
Updated: Jul 15, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications
Samar M Hammad1, Maria F Lopes-Virella2,3
1Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
Sphingolipids, particularly ceramides, are implicated in diabetes development and complications. Circulating sphingolipid levels and lipoprotein content show promise as early biomarkers for predicting diabetes and its vascular issues.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Diseases
Background:
- Sphingolipids, notably ceramides, are increasingly recognized for their role in the pathogenesis of type 1 and type 2 diabetes.
- Existing research primarily focuses on the mechanistic pathways linking sphingolipids to diabetes development.
- The significance of circulating sphingolipid levels and their lipoprotein distribution as predictive biomarkers is an emerging area of investigation.
Purpose of the Study:
- To review the literature on sphingolipid-mediated mechanisms in diabetes and its complications.
- To emphasize the potential of circulating plasma sphingolipid levels and lipoprotein content as biomarkers.
- To explore the predictive value of sphingolipids for diabetes development and complications.
Main Methods:
- Comprehensive literature review of published studies.
- Analysis of research on sphingolipid metabolism and function in diabetes.
- Evaluation of studies investigating circulating sphingolipid levels and lipoprotein associations.
Main Results:
- Sphingolipids, especially ceramides, contribute to diabetes pathogenesis through various mechanisms.
- Circulating sphingolipid profiles and their carriage by lipoproteins are associated with diabetes and its complications.
- Early research suggests potential for sphingolipids as predictive biomarkers for diabetes and vascular complications.
Conclusions:
- Sphingolipid metabolism is integral to diabetes development and progression.
- Circulating sphingolipid levels and lipoprotein profiles offer promising avenues for biomarker development.
- Further research into sphingolipid biomarkers could lead to novel therapeutic strategies for diabetes and its complications.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin Secretory Vesicles
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

